QOF advisors back ministers' bid for 'all or nothing' diabetes target
By Stephen Robinson, 17 December 2012
GPs could be forced to offer a battery of diabetes checks under a single 'all or nothing' QOF target worth thousands of pounds to the average practice, under plans set out by NICE advisors.
GPs would need to provide eight annual care checks to patients with diabetes to earn any points under the indicator, approved for development by NICE advisors last week.
Ministers want GPs to offer more diabetes care reviews, including foot checks and urinary albumin testing, following criticism that too few patients are receiving all the recommended checks.
But the 'all or nothing' target could see GPs lose QOF income if just a few patients missed out on all eight checks.
UK health departments had asked NICE's expert advisory panel to consider replacing the separate diabetes checks QOF indicators - worth around £10,000 - with one single composite indicator. A committee of MPs recently criticised the NHS and GPs for failing to offer diabetes patients all nine annual care checks recommended in NICE guidance.
But NICE advisors rejected ministers' calls for the full nine checks to be included, warning that retinopathy screening fell outside GPs' control. However, at a meeting in Manchester last week, NICE's advisory panel, consisting mostly of GPs, agreed to develop a composite indicator for piloting.
Not all panel members backed the move. One panel member said the idea was 'wrong in principle' and argued that, for some patients, providing the best care did not mean conducting all nine checks every year. Others warned the proposal would lead to mass exception reporting.
Advisors agreed to develop a bundled indicator that would exclude checks falling outside of GPs' control. They also said some points should remain in the current indicators for diabetes checks to protect part of practices' QOF income.
The work will pass to NICE's indicator development team, which will report back in June. If approved, the provisional indicator will then undergo piloting.
- Related MIMS Tables
- Finger Prickers and Compatible Lancets
- Insulin Preparations
- Blood Glucose Testing Strips and Meters
- Related MIMS Guidelines and Summaries
- Dapagliflozin in Combination Therapy for Treating Type 2 Diabetes (TA288)
- Exenatide Prolonged-Release Suspension for Injection in Combination with Oral Antidiabetic Therapy for the Treatment of Type 2 Diabetes (TA248)
- Liraglutide for the Treatment of Type 2 Diabetes Mellitus (TA203)
Latest Articles from GP
- Vitamin D deficiency doubles risk of chronic musculoskeletal pain
- GP fronts poster campaign to reduce use of A&E
- GP contract in 2014/15 to benefit average practice by just £114
- Health check roll-out by councils 'ineffective', charity warns
- Quarter of CCGs face 2014/15 deficit as experts urge NHS funding rise
Latest jobs Jobs web feed
- Salaried GP Gloucester House Medical Centre Competitive Salary , Urmston, Trafford
- Full or part-time Salaried GP Opportunity, Hampshire Coast Merco Excellent salary + GMC paid, Hampshire, South East region
- GP Jobs Calgary and Edmonton, Alberta, Canada EU Health Staff Ltd Between $280,000 and $325,000 or more , Alberta in Canada
- GP Salford Health Matters Competitive salary, Salford
- Salaried GP Required Yeading Medical Centre Up to £75,000 per annum negotiable, Yeading, Middlesex
- Locum GP Essex OOH MSI Group Ltd Hourly rates agreed individually , Essex - North London - East London - Suffolk - Herfordshire - Cambridgeshire - Berkshire